America has an Alzheimer’s problem. Can Trump fix it?
America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs.
TL;DR
- Over 7 million Americans over 65 have Alzheimer's dementia, a number projected to double by 2050.
- Annual costs for Alzheimer's and related dementias are estimated at over $1 trillion, potentially reaching $3 trillion by 2050.
- Government spending in 2025 was $250 billion, with over $4 billion allocated to research.
- New disease-modifying treatments like aducanumab, lecanemab, and donanemab have been approved, targeting amyloid plaques.
- These drugs have shown modest success in slowing disease progression but are expensive and have side effects.
- A more nuanced understanding of Alzheimer's implicates amyloid and tau dysregulation, vascular injury, inflammation, and metabolic dysfunction.
- The drug development pipeline is evolving with 138 novel agents, including immunotherapies.
- A proposal suggests an 'Operation Warp Speed'-like model with an Alzheimer's acceleration fund, potentially costing $5-$10 billion, to speed up therapeutic development.
- This fund could invest in preventive therapies, improve trial infrastructure, and utilize advance purchasing agreements for cost reduction.
- The article advocates for viewing the search for an Alzheimer's cure as a national priority.